Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Plos One|May 3, 2011
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancersÅslaug Helland, Michael S Anglesio, Joshy George, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Elife|December 23, 2020
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanismKrystal Ann Orlando, Amber K Douglas, Aierken Abudu, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Nature Communications|May 20, 2023
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-lossXianbing Zhu, Zheng Fu, Shary Y Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsFelix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Plos One|May 3, 2011
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancersÅslaug Helland, Michael S Anglesio, Joshy George, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Elife|December 23, 2020
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanismKrystal Ann Orlando, Amber K Douglas, Aierken Abudu, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Nature Communications|May 20, 2023
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-lossXianbing Zhu, Zheng Fu, Shary Y Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsFelix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
Pageof 32